MedGenome

Decoding genetic information to improve global health.

Bengaluru, India · Founded 2013 · $161.5M raised

Headquarters
Bengaluru
Employees
201–500
Founded
2013
Business Model
B2B
Total Funding
$161.5M
Last Round
$47.5M Series EJul 2025
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 6 investors for this company. The full record is or through the API.

About

MedGenome is a global leader in genomics-based diagnostics and research services, offering over 1,300 genetic tests spanning oncology, rare diseases, prenatal diagnostics, neurology, and infectious diseases. Founded in 2013 and headquartered in Bangalore, India, MedGenome operates across three core business lines: genomic diagnostics for clinical use, genomic research services for pharmaceutical and biotech partners, and drug discovery solutions powered by real-world genomic data. The company provides DNA sequencing, bioinformatics analysis, and multiomics services to healthcare providers, research institutions, and biopharma companies globally. Its US arm was rebranded as Signios Biosciences in 2025, offering sequencing and multiomics services from Foster City, California.

Summary

MedGenome is a Biotech company based in Bengaluru, India, founded in 2013. It has raised $161.5M in total across 5 rounds, most recently a $47.5M Series E round in Jul 2025. Investors include Novo Holdings A/S, Sequoia Capital and Maj Invest.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries EJul 2025
$47.5M

Sign up to see all 5 events

Funding: Series C through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MedGenome on Indexed.vc
<a href="https://indexed.vc/companies/medgenome"><img src="https://indexed.vc/api/badge/company/medgenome" alt="MedGenome on Indexed.vc" width="260" height="76" /></a>